Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Video: Gyrolab xPlore™ (Gyros)

11 Feb 2015
Automation

Gyros introduces Gyrolab xPlore™, a single-CD, cost-effective tool making automated nanoliter-scale immunoassays accessible to laboratories of every size.

Gyrolab xPlore gives your team the agility to develop assays more quickly and increase data quality with reduced hands-on time, reliably and precisely in every phase of biotherapeutic product development.

Streamio_Gyrolab

 

 View the video here.

 

 

 

 

 

Top content

  • An author’s perspective: NAN technology with Cheryl Arrowsmith and Alexander Jackson
  • LC-DIA-MS/MS reveals aging- and pathology-specific molecular alterations in aging and Alzheimer’s disease
  • What to look out for at Analytica 2026

Related tags

immunoassay
Previous article Next article

Related articles

22 NOV 2012 CLINICAL
Application of commercial research-grade biomarker assays in drug development: is it time to create ‘pharmaceutical-grade’ kits?
9 NOV 2016 JOURNAL ARTICLES
Transfer from research/academia to clinical/regulated
19 DEC 2011 CHROMATOGRAPHY
Microfluidic paper-based analytical devices: from POCKET to paper-based ELISA
31 AUG 2022 JOURNAL ARTICLES
Critical reagent generation, characterization, handling and storage workflows: impact on ligand binding assays
Immunogenicity
17 JUN 2021 IMMUNOGENICITY
eBook: The bioanalytical challenges and considerations of immunogenicity
3 JUN 2014 GENERAL INTEREST
Paper-based immunoassay could lead to simple and cost-effective hepatitis C diagnosis
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone